MQS Management LLC Takes $241,000 Position in Bath & Body Works, Inc. (NYSE:BBWI)

MQS Management LLC bought a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 7,540 shares of the company’s stock, valued at approximately $241,000.

Other hedge funds have also bought and sold shares of the company. Missouri Trust & Investment Co purchased a new position in shares of Bath & Body Works during the third quarter worth approximately $1,178,000. Aigen Investment Management LP purchased a new position in shares of Bath & Body Works during the third quarter worth approximately $368,000. Diamond Hill Capital Management Inc. purchased a new position in shares of Bath & Body Works during the third quarter worth approximately $15,169,000. Los Angeles Capital Management LLC raised its stake in shares of Bath & Body Works by 404.4% during the third quarter. Los Angeles Capital Management LLC now owns 134,544 shares of the company’s stock worth $4,295,000 after acquiring an additional 107,868 shares in the last quarter. Finally, River Global Investors LLP raised its stake in shares of Bath & Body Works by 22.2% during the third quarter. River Global Investors LLP now owns 40,081 shares of the company’s stock worth $1,279,000 after acquiring an additional 7,286 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Bath & Body Works news, CEO Gina Boswell bought 6,000 shares of the firm’s stock in a transaction on Wednesday, October 9th. The stock was acquired at an average price of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares in the company, valued at $7,202,134.68. This represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 0.27% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. BMO Capital Markets reissued an “outperform” rating and set a $50.00 price target (down from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. Robert W. Baird decreased their target price on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a research note on Thursday, August 29th. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $42.00 target price on shares of Bath & Body Works in a research note on Thursday, September 26th. Citigroup decreased their target price on shares of Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 20th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a research note on Thursday, August 29th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $42.44.

Read Our Latest Stock Analysis on BBWI

Bath & Body Works Trading Up 0.7 %

Shares of BBWI stock opened at $31.54 on Friday. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99. The stock has a market cap of $6.91 billion, a PE ratio of 7.64, a price-to-earnings-growth ratio of 1.00 and a beta of 1.79. The company’s fifty day moving average price is $30.18 and its 200-day moving average price is $36.49.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. On average, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.54%. The ex-dividend date of this dividend is Friday, November 22nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.37%.

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Featured Stories

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.